NCT07394946 2026-02-20
NELOPHER
Cancer Care Hospital & Research Centre Foundation, Lahore
Phase 2 Not yet recruiting
Clinical Trials
4 trialsNCT07305246 2025-12-26
Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer
First Hospital of China Medical University
Phase 2 Not yet recruiting
NCT07101159 2025-08-03
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05979220 2023-08-07
Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy
West China Hospital
Phase 2 Not yet recruiting